Abstract:Cell entry of severe acute respiratory coronavirus-2 (SARS-CoV-2) and other CoVs can occur via two distinct routes. Following receptor binding by the spike glycoprotein, membrane fusion can be triggered by spike cleavage either at the cell surface in a transmembrane serine protease 2 (TMPRSS2)-dependent manner or within endosomes in a cathepsin-dependent manner. Cellular sialoglycans have been proposed to aid in CoV attachment and entry, although their functional contributions to each entry pathway are unknown. In this study, we used genetic and enzymatic approaches to deplete sialic acid from cell surfaces and compared the requirement for sialoglycans during endosomal and cell-surface CoV entry using lentiviral particles pseudotyped with the spike proteins of different sarbecoviruses. We show that entry of SARS-CoV-1, WIV1-CoV and WIV16-CoV, like the SARS-CoV-2 omicron variant, depends on endosomal cathepsins and requires cellular sialoglycans for entry. Ancestral SARS-CoV-2 and the delta variant can use either pathway for entry, but only require sialic acid for endosomal entry in cells lacking TMPRSS2. Binding of SARS-CoV-2 spike protein to cells did not require sialic acid, nor was sialic acid required for SARS-CoV-2 entry in TMRPSS2-expressing cells. These findings suggest that cellular sialoglycans are not strictly required for SARS-CoV-2 attachment, receptor binding or fusion, but rather promote endocytic entry of SARS-CoV-2 and related sarbecoviruses. In contrast, the requirement for sialic acid during entry of MERS-CoV pseudoparticles and authentic HCoV-OC43 was not affected by TMPRSS2 expression, consistent with a described role for sialic acid in merbecovirus and embecovirus cell attachment. Overall, these findings clarify the role of sialoglycans in SARS-CoV-2 entry and suggest that cellular sialoglycans mediate endosomal, but not cell-surface, SARS-CoV-2 entry. The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in over 700 million infections and 7 million deaths so far, demonstrating the threat posed by emerging CoVs. In humans, SARS-CoV-2 and related coronaviruses cause respiratory tract infections, such as the common cold, as well as more severe disease in some individuals. To prepare for future outbreaks, conserved steps in the CoV replication could be considered for antiviral prophylactic or therapeutic approaches. One such process is CoV cell entry, which occurs via two main routes: At the cell surface or within endosomes. Cellular receptors, proteases and complex sugars, known as glycans, mediate CoV entry steps. In this study, we compared the role of a specific glycan subset, sialoglycans, in endosomal and cell surface CoV entry. We show that sialoglycans are required for entry of various CoVs that are mainly dependent on the endosomal route, but in the case of SARS-CoV-2, sialoglycans were not required when the cell-surface entry route was available. Our findings contribute to understanding the mechanisms of CoV entry, which could inform development of pan-CoV antivirals that target CoV entry steps.

Importance of Cholesterol-Rich Membrane Microdomains in the Interaction of the S Protein of SARS-coronavirus with the Cellular Receptor Angiotensin-Converting Enzyme 2

Characterization of the Role of the S Protein of Coronaviruses for Virus Entry

Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification

Cholesterol Metabolism--Impact for SARS-CoV-2 Infection Prognosis, Entry, and Antiviral Therapies

Membrane Activity and Viroporin Assembly for the SARS-CoV-2 E Protein Are Regulated by Cholesterol

Cholesterol is Important for a Post-Adsorption Step in the Entry Process of Transmissible Gastroenteritis Virus

Cholesterol is important for a post-adsorption step in the entry process of transmissible gastroenteritis virus.

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor

Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

Effect of chitooligosaccharide on the binding domain of the SARS-COV-2 receptor

Cholesterol and COVID-19--therapeutic opportunities at the host/virus interface during cell entry

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Lipid rafts disruption by statins negatively impacts the interaction between SARS-CoV-2 S1 subunit and ACE2 in intestinal epithelial cells

Cellular Membrane Cholesterol is Required for Porcine Reproductive and Respiratory Syndrome Virus Entry and Release in MARC-145 Cells

SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets

Endocytosis of the Receptor-Binding Domain of SARS-CoV Spike Protein Together with Virus Receptor ACE2

Peptide Domain Involved in the Interaction Between Membrane Protein and Nucleocapsid Protein of SARS-associated Coronavirus

Cellular sialoglycans are differentially required for endosomal and cell-surface entry of SARS-CoV-2 in lung cell lines

Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne

A Novel Unrecognized Mechanism for SARS-CoV-2 Immune-Mediated Pathology